Nexletol

Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit
Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit
Fierce Pharma
Esperion Therapeutics
Daiichi Sankyo
Nexletol
SEC
Flag link:
Daiichi torches Esperion’s Nexletol milestone promises
Daiichi torches Esperion’s Nexletol milestone promises
EP Vantage
Daiichi Sankyo
Esperion Therapeutics
Nexletol
Flag link:
ACC 2023 – Esperion’s outcomes win looks lacklustre
ACC 2023 – Esperion’s outcomes win looks lacklustre
EP Vantage
Esperion Therapeutics
ACC
Nexletol
cholesterol
Flag link:
Esperion gets out the budget ax, chopping 170 staffers as its big drug launch sputters
Esperion gets out the budget ax, chopping 170 staffers as its big drug launch sputters
Endpoints
Esperion Therapeutics
layoffs
FDA
Nexletol
bempadoic acid
Flag link:
Esperion strikes Japan deal for 'goldilocks' cholestrol drug, bags $60M cash as pandemic forces virtual US rollout
Esperion strikes Japan deal for 'goldilocks' cholestrol drug, bags $60M cash as pandemic forces virtual US rollout
Endpoints
Esperion
Nexletol
Nexlizet
Japan
cholesterol
Flag link:
ACC: Esperion's Nexletol busts cholesterol levels regardless of statin, ezitimibe therapy
ACC: Esperion's Nexletol busts cholesterol levels regardless of statin, ezitimibe therapy
Fierce Pharma
ACC
Esperion
Nexletol
clinical trials
c-reactive protein
Flag link:
Esperion shifts to show not tell
Esperion shifts to show not tell
EP Vantage
Esperion Therapeutics
bempedoic acid
Nexletol
Flag link:
Esperion adds more competition to cholesterol drug market with newly approved drug
Esperion adds more competition to cholesterol drug market with newly approved drug
BioPharma Dive
Esperion Therapeutics
cholesterol
bempedoic acid
FDA
Nexletol
Flag link: